112 related articles for article (PubMed ID: 12969773)
1. The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock.
Collin M; Thiemermann C
Eur J Pharmacol; 2003 Aug; 476(3):257-8. PubMed ID: 12969773
[TBL] [Abstract][Full Text] [Related]
2. 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria.
Dugo L; Collin M; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Sep; 498(1-3):295-301. PubMed ID: 15364008
[TBL] [Abstract][Full Text] [Related]
3. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin.
Collin M; Patel NS; Dugo L; Thiemermann C
Crit Care Med; 2004 Mar; 32(3):826-31. PubMed ID: 15090969
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.
Abdelrahman M; Collin M; Thiemermann C
Shock; 2004 Dec; 22(6):555-61. PubMed ID: 15545828
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
6. Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock.
Collin M; Abdelrahman M; Thiemermann C
Eur J Pharmacol; 2004 Feb; 486(2):233-5. PubMed ID: 14975712
[TBL] [Abstract][Full Text] [Related]
7. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
[TBL] [Abstract][Full Text] [Related]
10. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
Butler R; Mitchell SH; Tindall DJ; Young CY
Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
12. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.
Chatterjee PK; Patel NS; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Eberhardt W; Pfeilschifter J; Thiemermann C
Cardiovasc Res; 2004 Feb; 61(3):630-43. PubMed ID: 14962493
[TBL] [Abstract][Full Text] [Related]
13. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N
J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171
[TBL] [Abstract][Full Text] [Related]
14. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
17. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
19. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
20. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]